C-reactive protein and coronary artery disease: influence of obesity, caloric restriction and weight loss

被引:52
作者
Heilbronn, LK [1 ]
Clifton, PM [1 ]
机构
[1] CSIRO, Adelaide, SA 5000, Australia
关键词
CRP; adipose tissue; IL-6; weight loss;
D O I
10.1016/S0955-2863(02)00187-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
C reactive protein (CRP) values in blood are a good indicator of the likelihood of acute coronary and cerebral events in both healthy subjects and patients with coronary artery disease. This indicates that atherosclerotic lesions rich in inflammatory cells and cytokines are more likely to produce acute events either through vasospasm and/or thrombosis and also can be readily detected through elevations in CRP when measured using a high sensitivity assay (hsCRP). However the arterial wall is only one potential source of cytokines which induce CRP production. Fat cells also produce cytokines, in particular IL-6 which induces the synthesis of CRP by the liver. Obesity, especially abdominal obesity, is associated with elevations of hsCRP. This may be of pathogenic significance as CRP stimulates the uptake of LDL by macrophages, induces complement activation which may cause cellular damage in the artery, and enhances monocyte production of tissue factor, thus enhancing the risk of thrombosis. Caloric restriction and weight loss lowers IL-6 and CRP levels and may beneficially suppress an immune response. Whether particular dietary macronutrients or micronutrients alter IL-6 or CRP is unknown but this issue is clearly becoming more important. (C) 2002 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:316 / 321
页数:6
相关论文
共 70 条
[1]   Effect of statin therapy on C-reactive protein levels - The Pravastatin Inflammation/CRP Evaluation (PRINCE): A randomized trial and cohort study [J].
Albert, MA ;
Danielson, E ;
Rifai, N ;
Ridker, PM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (01) :64-70
[2]  
Amrani Y, 2001, MOL PHARMACOL, V60, P646
[3]   Serum levels of C-reactive protein are associated with obesity, weight gain, and hormone replacement therapy in healthy postmenopausal women [J].
Barinas-Mitchell, E ;
Cushman, M ;
Meilahn, EN ;
Tracy, RP ;
Kuller, LH .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (11) :1094-1101
[4]   The relation of markers of inflammation to the development of glucose disorders in the elderly - The cardiovascular health study [J].
Barzilay, JI ;
Abraham, L ;
Heckbert, SR ;
Cushman, M ;
Kuller, LH ;
Resnick, HE ;
Tracy, RP .
DIABETES, 2001, 50 (10) :2384-2389
[5]   Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss [J].
Bastard, JP ;
Jardel, C ;
Bruckert, E ;
Blondy, P ;
Capeau, J ;
Laville, M ;
Vidal, H ;
Hainque, B .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (09) :3338-3342
[6]   C-REACTIVE PROTEIN-LEVELS AS A DIRECT INDICATOR OF INTERLEUKIN-6 LEVELS IN HUMANS INVIVO [J].
BATAILLE, R ;
KLEIN, B .
ARTHRITIS AND RHEUMATISM, 1992, 35 (08) :982-983
[7]   CHARACTERIZATION OF DIFFERENTIATION FACTOR LEUKEMIA INHIBITORY FACTOR EFFECT ON LIPOPROTEIN-LIPASE ACTIVITY AND MESSENGER-RNA IN 3T3-L1 ADIPOCYTES [J].
BERG, M ;
FRAKER, DL ;
ALEXANDER, HR .
CYTOKINE, 1994, 6 (04) :425-432
[8]   ELEVATION OF C-REACTIVE PROTEIN IN ACTIVE CORONARY-ARTERY DISEASE [J].
BERK, BC ;
WEINTRAUB, WS ;
ALEXANDER, RW .
AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (03) :168-172
[9]   Complement and atherogenesis - Binding of CRP to degraded, nonoxidized LDL enhances complement activation [J].
Bhakdi, S ;
Torzewski, M ;
Klouche, M ;
Hemmes, M .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (10) :2348-2354
[10]   C-REACTIVE PROTEIN INDUCES HUMAN PERIPHERAL-BLOOD MONOCYTES TO SYNTHESIZE TISSUE FACTOR [J].
CERMAK, J ;
KEY, NS ;
BACH, RR ;
BALLA, J ;
JACOB, HS ;
VERCELLOTTI, GM .
BLOOD, 1993, 82 (02) :513-520